Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1969 Oct;5(4):319–340.

Studies on experimental autoimmune thymitis in guinea-pigs

J R Kalden, W G Williamson, R J Johnston, W J Irvine
PMCID: PMC1579133  PMID: 4311730

Abstract

Normal and thymectomized outbred guinea-pigs were immunized with extracts of calf thymus, calf skeletal muscle or calf heart muscle emulsified in Freund's complete adjuvant. Immunization with either thymus or skeletal muscle produced a significant incidence of thymitis and a partial neuromuscular block in contrast to control animals either untreated or injected with an extract of calf lymph node or saline in Freund's complete adjuvant. The incidence of thymitis and partial neuromuscular block in animals that were injected with an extract of calf heart muscle in Freund's complete adjuvant was found not to be significant when compared to the control animals.

Neuromuscular transmission was studied using Copeland–Davis clip electrodes or a bipolar silver wire electrode threaded through the flexor digitorum muscle. The development of partial neuromuscular block in the test animals was found to be dependent on the presence of the thymus. All animals with a partial neuromuscular block had evidence of experimental thymitis.

These findings are in keeping with the hypothesis that a factor released by the thymus may be important in the development of the neuromuscular block characteristic of myasthenia gravis.

Full text

PDF
319

Images in this article

324FIG. 2
on p.324
327FIG. 3
on p.327
330FIG. 5
on p.330

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEUTNER E. H., WITEBSKY E., RICKEN D., ADLER R. H. Studies on autoantibodies in myasthenia gravis. JAMA. 1962 Oct 6;182:46–58. [PubMed] [Google Scholar]
  2. COPLAND J. G., DAVIES C. T. A SIMPLE CLINICAL SKIN ELECTRODE. Lancet. 1964 Feb 22;1(7330):416–416. doi: 10.1016/s0140-6736(64)92794-1. [DOI] [PubMed] [Google Scholar]
  3. Castleman B. The pathology of the thymus gland in myasthenia gravis. Ann N Y Acad Sci. 1966 Jan 26;135(1):496–505. doi: 10.1111/j.1749-6632.1966.tb45497.x. [DOI] [PubMed] [Google Scholar]
  4. DAVIES A. M., LAUFER A., GERY I., ROSENMANN E. ORGAN SPECIFICITY OF THE HEART. 3. CIRCULATING ANTIBODIES AND IMMUNOPATHOLOGICAL LESIONS IN EXPERIMENTAL ANIMALS. Arch Pathol. 1964 Oct;78:369–376. [PubMed] [Google Scholar]
  5. Desmedt J. E. Presynaptic mechanisms in myasthenia gravis. Ann N Y Acad Sci. 1966 Jan 26;135(1):209–246. doi: 10.1111/j.1749-6632.1966.tb45474.x. [DOI] [PubMed] [Google Scholar]
  6. Fenichel G. M. Muscle lesions in myasthenia gravis. Ann N Y Acad Sci. 1966 Jan 26;135(1):60–67. doi: 10.1111/j.1749-6632.1966.tb45463.x. [DOI] [PubMed] [Google Scholar]
  7. Goldstein G., Hofmann W. W. Electrophysiological changes similar to those of myasthenia gravis in rats with experimental autoimmune thymitis. J Neurol Neurosurg Psychiatry. 1968 Oct;31(5):453–459. doi: 10.1136/jnnp.31.5.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goldstein G., Strauss A. J., Pickeral S. Antigens in thymus and muscle effective in inducing experimental autoimmune thymitis and the release of thymin. Clin Exp Immunol. 1969 Jan;4(1):3–16. [PMC free article] [PubMed] [Google Scholar]
  9. Goldstein G. The thymus and neuromuscular function. A substance in thymus which causes myositis and myasthenic neuromuscular block in guineapigs. Lancet. 1968 Jul 20;2(7560):119–122. doi: 10.1016/s0140-6736(68)90414-5. [DOI] [PubMed] [Google Scholar]
  10. Goldstein G. Thymitis and myasthenia gravis. Lancet. 1966 Nov 26;2(7474):1164–1167. doi: 10.1016/s0140-6736(66)90479-x. [DOI] [PubMed] [Google Scholar]
  11. Goldstein G., Whittingham S. Experimental autoimmune thymitis. An animal model of human myasthenia gravis. Lancet. 1966 Aug 6;2(7458):315–318. doi: 10.1016/s0140-6736(66)92599-2. [DOI] [PubMed] [Google Scholar]
  12. Goldstein G., Whittingham S. Histological and serological features of experimental autoimmune thymitis in guinea-pigs. Clin Exp Immunol. 1967 May;2(3):257–268. [PMC free article] [PubMed] [Google Scholar]
  13. HOFMANN W. W., STEMMER E. A. Subthreshold activity at normal and myasthenic end plates. Neurology. 1963 Mar;13:227–236. doi: 10.1212/wnl.13.3.227. [DOI] [PubMed] [Google Scholar]
  14. MARSHALL A. H., WHITE R. G. The immunological reactivity of the thymus. Br J Exp Pathol. 1961 Aug;42:379–385. [PMC free article] [PubMed] [Google Scholar]
  15. Namba T., Grob D. Autoantibodies and myasthenia gravis, with special reference to muscle ribonucleoprotein. Ann N Y Acad Sci. 1966 Jan 26;135(1):606–630. doi: 10.1111/j.1749-6632.1966.tb45508.x. [DOI] [PubMed] [Google Scholar]
  16. Osserman K. E., Genkins G. Critical reappraisal of the use of edrophonium (tensilon) chloride tests in myasthenia gravis and significance of clinical classification. Ann N Y Acad Sci. 1966 Jan 26;135(1):312–334. doi: 10.1111/j.1749-6632.1966.tb45479.x. [DOI] [PubMed] [Google Scholar]
  17. Parkes J. D. Attempted production of myasthenia gravis in the rat. Br J Exp Pathol. 1966 Dec;47(6):577–585. [PMC free article] [PubMed] [Google Scholar]
  18. Parkes J. D., McKinna J. A. Effects of thymic extract on the neuromuscular junction. Nature. 1967 Jun 10;214(5093):1116–1117. doi: 10.1038/2141116a0. [DOI] [PubMed] [Google Scholar]
  19. STRAUSS A. J. Myasthenia gravis. Br Med J. 1963 Jan 5;1(5322):56–57. doi: 10.1136/bmj.1.5322.56-d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Strauss A. J., Smith C. W., Cage G. W., van der Geld H. W., McFarlin D. E., Barlow M. Further studies on the specificity of presumed immune associations of myasthenia gravis and consideration of possible pathogenic implications. Ann N Y Acad Sci. 1966 Jan 26;135(1):557–579. doi: 10.1111/j.1749-6632.1966.tb45504.x. [DOI] [PubMed] [Google Scholar]
  21. Strauss A. J., van der Geld H. W., Kemp P. G., Jr, Exum E. D., Goodman H. C. Immunological concomitants of myasthenia gravis. Ann N Y Acad Sci. 1965 Jun 30;124(2):744–766. doi: 10.1111/j.1749-6632.1965.tb18999.x. [DOI] [PubMed] [Google Scholar]
  22. Thesleff S. Acetylcholine utulization in myasthenia gravis. Ann N Y Acad Sci. 1966 Jan 26;135(1):195–208. doi: 10.1111/j.1749-6632.1966.tb45473.x. [DOI] [PubMed] [Google Scholar]
  23. WELLER T. H., COONS A. H. Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro. Proc Soc Exp Biol Med. 1954 Aug-Sep;86(4):789–794. doi: 10.3181/00379727-86-21235. [DOI] [PubMed] [Google Scholar]
  24. WILSON A., OBRIST A. R., WILSON H. Some effects of extracts of thymus glands removed from patients with myasthenia gravis. Lancet. 1953 Aug 22;265(6782):368–371. doi: 10.1016/s0140-6736(53)91403-2. [DOI] [PubMed] [Google Scholar]
  25. van der Geld H. W., Strauss A. J. Myasthenia gravis. Immunological relationship between striated muscle and thymus. Lancet. 1966 Jan 8;1(7428):57–60. doi: 10.1016/s0140-6736(66)92356-7. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES